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Introduction: Measuring renal function in acute kidney injury (AKI) is
difficult. The criteria on which a clinical diagnosis of AKI is made are
broad and open to interpretation. More objective measures remain
elusive. A truly robust biomarker has not been discovered and ex-
ogenous markers are difficult to use in critically ill patients. We have
previously used measures of renal clearance of Iohexol (rICl) to evalu-
ate AKI (data submitted) and have shown that 1-hour renal creatinine
clearances (1-CrCl) correlate well with rICl (correlation r = 0.99; Bland
Altman bias −5.6, SD 24.1 %) performing better than 4 hourly CrCl
measurements (bias 11.4 % SD 56.7 %).
Objective: To use sequential 1-CrCl measurements to measure renal
function in critically ill patients with or at risk of AKI over 72 hours
and to compare this with traditional methods of assessing AKI. This
was part of a BSc project.
Methods: Consent was obtained from the next of kin according to
ethical review (NREC: 15/LO/1720). 1-hour urine samples were col-
lected at 7 am and 7 pm. Serum creatinine (SCr) samples were taken
30 min after the urine collections were started. SCr and urinecreatinine (UCr) concentrations were measured using the enzymatic
method by the dedicated researcher. 1-CrCl was calculated by the
equation: CrCl ¼ ðUCr  volÞ1:73=ððSCr /min)xBSA). 1-CrCls were
compared with the ´kidney disease improving global outcomes´
(KDIGO) criteria for AKI and estimated glomerular filtration rates
(eGFR) calculated by the Cockcroft-Gault (CG), modification of diet in
renal disease 7 (MDRD7) and chronic kidney disease epidemiology
collaboration (CKI-EPI) methods. Kruskal Wallis, Spearman correlation
and the Bland-Altman method were used (IBM® SPSS® version 22) in
analysis.
Results: 17 patients were included with a total of 87 1-CrCl measure-
ments. Median (IQR) age was 67 (50–76) and admission APACHE II
score 22 (22–32). 14 patients were medical admissions and 3 had
emergency surgery. Observed overtime the 1-CrCl changed in similar
patterns to the calculated eGFR (Figs. 49 and 50, examples) and cor-
relations were good (1-CrCl vs CG r = 0.857, 1-CrCl vs CKD-epi = 0.861,
1-CrCl vs MDRD7 = 0.845). However the eGFR did not predict actual
values. The Bland Altman comparisons for CKD-epi and MDRD7 are
in Table 28. Fig 51 compares 1-CrCl with the KDIGO criteria
Conclusions: Despite good correlations, the eGFR calculated values
were not good measures of actual renal function. 1-CrCl was often al-
though not always markedly lower than the eGFR. The KDIGO criteria
did reflect the measured 1-CrCl but there was marked overlap in all
categories.
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Table 28 (abstract A922). Bland Altman comparison of 1-CrCl with
eGFR
Comparison Bias (%) SD(%) Limits of Agreement (%)
1CrCl vs CKD-epi −6.5 21.3 −39.4 to 44.1
1CrCl vs MDRD7 2.4 20.5 −46.5 to 33.9
Fig. 51 (abstract A922). Boxplot of KDIGO and 1 hour CrCl
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